IP Verse

Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains

Patent No. EP3228315 (titled "Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains") was filed by Amgen Research Munich on Oct 27, 2011. The application was issued on Nov 25, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
F HOFFMANN LA ROCHEAug 24, 2021MEWBURN ELLIS
JAMES POOLEAug 24, 2021CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3228315

AMGEN RESEARCH MUNICH
Application Number
EP17159560A
Filing Date
Oct 27, 2011
Status
Granted And Under Opposition
Oct 23, 2020
Publication Date
Nov 25, 2020
External Links
Slate, Register , Google Patents